Search Results - "Krzyzanowska, M"

Refine Results
  1. 1

    How may clinical research improve healthcare outcomes? by KRZYZANOWSKA, M. K, KAPLAN, R, SULLIVAN, R

    Published in Annals of oncology (01-11-2011)
    “…Healthcare outcomes such as overall survival or quality of life are the end results of a complex interaction between the patient, treatment and the healthcare…”
    Get full text
    Conference Proceeding Journal Article
  2. 2

    Impact of early palliative care on caregivers of patients with advanced cancer: cluster randomised trial by McDonald, J., Swami, N., Hannon, B., Lo, C., Pope, A., Oza, A., Leighl, N., Krzyzanowska, M.K., Rodin, G., Le, L.W., Zimmermann, C.

    Published in Annals of oncology (01-01-2017)
    “…Early palliative care improves the quality of life (QoL) and satisfaction with care of patients with advanced cancer, but little is known about its effect on…”
    Get full text
    Journal Article
  3. 3

    Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy? by Barbera, L., Sutradhar, R., Howell, D., Sussman, J., Seow, H., Dudgeon, D., Atzema, C., Earle, C., Husain, A., Liu, Y., Krzyzanowska, M. K.

    Published in Supportive care in cancer (01-10-2015)
    “…Background In 2007, the provincial cancer agency in Ontario, Canada initiated a wide-scale program to screen for symptoms in the cancer population using the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Biological aspects of human migration and mobility by Mascie-Taylor, C. G. N., Krzyżanowska, M.

    Published in Annals of human biology (04-07-2017)
    “…This paper reviews how migration, both geographical and social, impacts on variation in some human biological traits. Migration and mobility are considered in…”
    Get full text
    Journal Article
  6. 6

    Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis by Berry, S.R., Cosby, R., Asmis, T., Chan, K., Hammad, N., Krzyzanowska, M.K.

    Published in Annals of oncology (01-03-2015)
    “…There are no clinically significant survival differences between continuous and intermittent strategies of delivering chemotherapy for first-line metastatic…”
    Get full text
    Journal Article
  7. 7

    A primer on the genetics of medullary thyroid cancer by Larouche, V, Akirov, A, Thomas, C M, Krzyzanowska, M K, Ezzat, S

    Published in Current oncology (Toronto) (01-12-2019)
    “…Medullary thyroid cancer is a rare type of neuroendocrine tumour that arises from the parafollicular cells (C cells) of the thyroid gland. It accounts for…”
    Get full text
    Journal Article
  8. 8

    A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer by Renouf, D. J., Hedley, D., Krzyzanowska, M. K., Schmuck, M., Wang, L., Moore, M. J.

    Published in Cancer chemotherapy and pharmacology (01-09-2016)
    “…Objectives AUY922 is a novel heat shock protein inhibitor with preclinical activity in pancreatic cancer. This phase II study evaluated the efficacy of AUY922…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis by Eskander, A., Krzyzanowska, M.K., Fischer, H.D., Liu, N., Austin, P.C., Irish, J.C., Enepekides, D.J., Lee, J., Gutierrez, E., Lockhart, E., Raphael, M., Singh, S.

    Published in Oral oncology (01-08-2018)
    “…•The proportion of patients in a given treatment-modality exposure who had at least one emergency department visit or unplanned hospitalization were as…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Technological Parameters of Dehydrochlorination of 1,3-Dichloropropan-2-ol to Epichlorohydrin by Krzyżanowska, Anna M, Milchert, Eugeniusz, Paździoch, Waldemar M

    “…The results of continuous dehydrochlorination of an 88 wt % aqueous solution of 1,3-dichloropropan-2-ol (13DCP2OL) to epichlorohydrin (EPI) are presented. The…”
    Get full text
    Journal Article
  13. 13

    Experiences of Canadian oncologists with difficult patient deaths and coping strategies used by Granek, L, Barbera, L, Nakash, O, Cohen, M, Krzyzanowska, M K

    Published in Current oncology (Toronto) (01-08-2017)
    “…We aimed to explore and identify what makes patient death more emotionally difficult for oncologists and how oncologists cope with patient death. A convenience…”
    Get full text
    Journal Article
  14. 14

    Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population by Booth, C.M, Nanji, S, Wei, X, Peng, Y, Biagi, J.J, Hanna, T.P, Krzyzanowska, M.K, Mackillop, W.J

    “…Abstract Aims Although guidelines do not recommend adjuvant chemotherapy (ACT) for stage II colon cancer, many state that ACT may be considered in high-risk…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Control of cardiovascular risk factors among adult cancer survivors: a population-based survey by Enright, K. A, Krzyzanowska, M. K

    Published in Cancer causes & control (01-11-2010)
    “…Introduction Cardiovascular disease (CVD) is a major cause of morbidity and mortality in cancer survivors, with the risk increasing significantly with the…”
    Get full text
    Journal Article
  17. 17

    Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study by Booth, C.M, Nanji, S, Wei, X, Biagi, J.J, Krzyzanowska, M.K, Mackillop, W.J

    Published in European journal of surgical oncology (01-02-2016)
    “…Abstract Background Most literature describing surgery for colorectal cancer (CRC) liver metastases (LM) comes from high volume centres. Here, we report…”
    Get full text
    Journal Article
  18. 18

    End of life care for women with gynecologic cancers by Barbera, L, Elit, L, Krzyzanowska, M, Saskin, R, Bierman, A.S

    Published in Gynecologic oncology (01-08-2010)
    “…Abstract Background Little is known about patterns of end of life (EOL) care in gynecologic cancer patients. This paper reports on five EOL quality indicators:…”
    Get full text
    Journal Article
  19. 19

    Cross-Canada differences in early-stage breast cancer treatment and acute-care use by Powis, M, Groome, P, Biswanger, N, Kendell, C, Decker, K M, Grunfeld, E, McBride, M L, Urquhart, R, Winget, M, Porter, G A, Krzyzanowska, M K

    Published in Current oncology (Toronto) (01-10-2019)
    “…Chemotherapy has improved outcomes in early-stage breast cancer, but treatment practices vary, and use of acute care is common. We conducted a pan-Canadian…”
    Get full text
    Journal Article
  20. 20